1. Naumov GN, Akslen LA, Folkman J.
Role of angiogenesis in human tumor dormancy - Animal models of the angiogenic switch
Cell Cycle 5(16): 1779-1787
Times Cited: 35

2. Orimo A, Weinberg RA
Stromal fibroblasts in cancer: A novel tumor-promoting cell type
Cell Cycle 5(15): 1597-1601
Times Cited: 24

3. van de Weerdt BCM, Medema RH
Polo-like kinases: A team in control of the division
Cell Cycle 5(8): 824-828
Times Cited: 22

4. Higa LA, Banks D, Min W, et al.
L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage
Cell Cycle 5(15): 1675-1680
Times Cited: 19

5. Yoeli-Lerner M, Toker A
Akt/PKB signaling in cancer: A function in cell motility and invasion
Cell Cycle 5(6): 603-605
Times Cited: 16

6. Li CX, Parker A, Menocal E, et al.
Delivery of RNA interference
Cell Cycle 5(18): 2103-2109
Times Cited: 18

7. Bradham C, McClay DR
p38 MAPK in development and cancer
Cell Cycle 5(8): 824-828
Times Cited: 18

8. Wilson IM, Davies JJ, Weber M, et al.
Epigenomics: Mapping the methylome
Cell Cycle 5(2): 155-158
Times Cited: 18

Updated 04/03/08

Why Publish in Cell Cycle?

Cell Cycle is an instant access journal of high priority research, with optional no fee publication (please refer to the section in the Author Guidelines regarding page charges) and optional immediate open access. Cell Cycle (indexed by PubMed/Medline and ISI) is a peer-reviewed journal in both print (traditional) and online formats with a distinguished editorial board and many of the most highly cited authors in the field. There are no restrictions on topics and formats for manuscript submitted. We will consider highly important work in any field of biology (from yeast to man) and medicine (from cancer to cardiology). The goal is instant publication of the most competitive research. High priority papers will be peer-reviewed and published on the day of submission. Typically, publication is free of charge (with color figures published online in PDF format at no cost). After one year, each paper is made open access in our archives. Immediate open access is optional (fees are less than in open access journals). Traditional publishing in print with optional color figures (a fee applies). Cell Cycle is an ideal vehicle for experimental reports:

• Rapid response to presubmission inquiries (usually within the hour). Most papers are rejected without external review. (papers send for external peer-review are expected to be published). During presubmission inquiry, reviewers will be contacted to accelerate further review. Authors are encouraged to suggest and decline potential reviewers.

• Ultra-rapid peer-review (usually within one-two days)

• Papers rejected from other top journals (e.g., Nature, Science, Cell), if the authors choose, may be submitted with previous reviews and decision letters. This allows for the consideration of a paper without sending for additional review.

• Ultra-rapid publication upon acceptance. In the optimal scenario, the paper may be published the day following acceptance.

• Ultra-rapid publication on PubMed/Medline with a link out to a full-length paper. Free of charge publication of brief articles (less than 5 pages). Please note that the Watson and Crick paper was just one page. There is no limit for the number of pages for modest page charges. Free publication of color figures on line and PDF (color is optional in traditional print).